| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 23413-80-1 | 乙酰水楊酸鋁 | Aluminum,bis[2-(acetyloxy)benzoato-kO]hydroxy-; Aluminum,bis[2-(acetyloxy)benzoato-O1]hydroxy-; Aluminum, hydroxybis(acetylsalicylato)-(7CI); Aluminum, hydroxybis(salicylic acid acetato)- (6CI,8CI); Benzoic acid,2-(acetyloxy)-, aluminum complex; Acetylsalicylate aluminum; Aluminum aspirin; Aluminum diacetylsalicylate; Aluminum DIASpirin; Aluminum,bis(acetylsalicylato)hydroxy-; Aspirin aluminum; Hypyrin; Monohydroxyaluminumbis(o-acetoxybenzoate); Monohydroxyaluminum diacetylsalicylate; Rumasal |  | C18H15AlO9 | 詳情 | 供應商 |
| 874908-14-2 | Benzoic acid,2-ethoxy-4-[2-[[1-[2-(3-hydroxy-1-piperidinyl)phenyl]-3-methylbutyl]amino]-2-oxoethyl]-; 2-Ethoxy-4-[2-[[1-[2-(3-hydroxy-1-piperidinyl)phenyl]-3-methylbutyl]amino]-2-oxoethyl]benzoic Acid; 3’-Hydroxy Repaglinide(Mixture of DIAStereomers) |  | C27H36N2O5 | 詳情 | 供應商 | |
| 127-60-6 | 醋地砜鈉; 醋地砜鈉; | Glycine,N-[4-[(4-aminophenyl)sulfonyl]phenyl]-, sodium salt (1:1); Glycine,N-(p-sulfanilylphenyl)-, monosodium salt (8CI); Glycine, N-(p-sulfanilylphenyl)-,sodium salt (7CI); Glycine, N-[4-[(4-aminophenyl)sulfonyl]phenyl]-, monosodiumsalt (9CI); AceDIASulfone sodium; Cilotropin; N-(p-Sulfanilylphenyl)glycinesodium salt; Sodium 4-carboxymethylamino-4'-aminodiphenylsulfone; SodiumaceDIASulfone; Solfone; Sulfon-cilag |  | C14H13N2NaO4S | 詳情 | 供應商 |
| 80-03-5 | Glycine,N-[4-[(4-aminophenyl)sulfonyl]phenyl]-; Glycine,N-(p-sulfanilylphenyl)- (6CI,8CI); AceDIASulfone; Ciloprin; N-(p-Sulfanilylphenyl)glycine; N-[p-(p-Aminophenylsulfonyl)phenyl]glycine; NSC158324; p,p'-Diaminodiphenyl sulfone-N-acetic acid |  | C14H14N2O4S | 詳情 | 供應商 | |
| 108535-37-1 | 1,3-Butanediol,4,4,4-trifluoro-1-phenyl-, [R-(R*,S*)]- (9CI); 4,4,4-TRIFLUORO-1-PHENYLBUTANE-1,3-DIOL; 4,4,4-TRIFLUORO-1-PHENYLBUTANE-1,3-DIOL (DIASTEREOMERIC MIXTURE) |  | C10H11F3O2 | 詳情 | 供應商 | |
| 109904-27-0 | Thieno[3,2-c]pyridine-5(4H)-aceticacid, a-(2-chlorophenyl)-2,6,7,7a-tetrahydro-2-oxo-,methyl ester; 2-Oxo Clopidogrel Hydrochloride (Mixture of DIAStereomers); a-(2-Chlorophenyl)-2,6,7,7a-tetrahydro-2-oxo-thieno[3,2-c]pyridine-5(4H)-acetic Acid Methyl Ester Hydrochlorid; α-(2-Chlorophenyl)-2,6,7,7a-tetrahydro-2-oxo-thieno[3,2-c]pyridine-5(4H)-acetic Acid Methyl Ester Hydrochloride; a-(2-Chlorophenyl)-2,6,7,7a-tetrahydro-2-oxo-thieno[3,2-c]pyridine-5(4H)-acetic Acid Methyl Ester Hydrochloride |  | C16H16ClNO3S | 詳情 | 供應商 | |
| 302911-92-8 | 2,3-Octanediol,8-bromo-2,6-dimethyl-; 8-BROMO-2,6-DIMETHYL-2,3-OCTANEDIOL, TECH., 90%, MIXTURE OF DIASTEREOMERS; 8-Bromo-2,6-dimethyl-2,3-octanediol,mixture of DIAStereomers |  | C10H21BrO2 | 詳情 | 供應商 | |
| 154784-36-8 | 2-Propanol,1,1'-[(1-methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-; 1,1[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol (Mixture of DIAStereomers); Metoprolol Impurity O; Metoprolol Impurity VII; Metoprolol Impurity VIII; Metoprolol Related compound D |  | C27H41NO6 | 詳情 | 供應商 | |
| 480438-81-1 | 3,3,3-Trifluoro-3-[(2-tetrahydrofuranyl)methyl]propionic acid, mixture of DIAStereomers |  | C8H11F3O3 | 詳情 | 供應商 | |
| 5398-25-4 | 2,3-Dibromopentane, mixture of DIAStereomers |  | C2H5CH(Br)CH(Br)CH3 | 詳情 | 供應商 | |
| 6423-02-5 | 2,3-Dibromohexane, mixture of DIAStereomers |  | CH3CH2CH2CH(Br)CH(Br)CH3 | 詳情 | 供應商 | |
| 3012-76-8 | (2E,4E,6E)-7-(4,4,7a-trimethyl-2,5,6,7-tetrahydrobenzofuran-2-yl)-3-me thyl-octa-2,4,6-trienoic acid; (2E,4E,6E)-7-(4,4,7a-trimethyl-2,5,6,7-tetrahydrobenzofuran-2-yl)-3-me thyl-octa-2,4,6-trienoic acid; 5,8-Dihydro-5,8-epoxyretinoic acid; 5,8-Epoxy-5,8-dihydroretinoic acid; 5,8-Monoepoxyretinoic acid; Retinoic acid, 5,8-epoxy-5,8-dihydro-; all-trans 5,8-Epoxy Retinoic Acid (Mixture of DIAStereomers) |  | C20H28O3 | 詳情 | 供應商 | |
| 210837-87-9 | 7-Deoxy Daunorubicinol Aglycone; 7-Deoxy Daunorubicinol Aglycone; 7-Deoxy Daunorubicinol Aglycone (Mixture of DIAStereomers) | 無 | 詳情 | 供應商 | ||
| 178383-76-1 | 4-Hydroxy Nebivolol, Hydrochloride Hydrate (Mixture of DIAStereomers) | 無 | 詳情 | 供應商 | ||
| 118-08-1 | 北美黃連堿 | (-)-BETA-HYDRASTINE; HYDRASTINE; HYDRASTINE, (-)-B-; (-)-BETA-HYDRASTINE; (-)-B-HYDIASTINE; (1R,9S)-(-)-BETA-HYDRASTINE; (1R,9S)-BETA-HYDRASTINE; [S-(R*,S*)]-6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-1(3H)-isobenzofuranone; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]- |  | C21H21NO6 | 詳情 | 供應商 |
| 53949-53-4 | 1-羥基異丁基苯基-1'-甲基丙酸 | Benzeneacetic acid, 4-(1-hydroxy-2-methylpropyl)--alpha--methyl- (9CI); Benzeneacetic acid, 4-(1-hydroxy-2-methylpropyl)--alpha--methyl- (9CI); 1-Hydroxy Ibuprofen (Ibuprofen Impurity L)(Mixture of DIAStereomers); 2-[4'-(1-Hydroxy-2-methylpropyl)phenyl]propionic Acid; 4-(1-Hydroxy-2-methylpropyl)-a-methylbenzeneacetic Acid |  | C13H18O3 | 詳情 | 供應商 |
| 96107-27-6 | 3-Hydroxy-2-propyl-4-pentenoic Acid Ethyl Ester (Mixture of DIAStereomers) | 無 | 詳情 | 供應商 | ||
| 184764-27-0 | 2-Methoxymethyl Montelukast 1,2-Diol (Mixture of DIAStereomers) | 無 | 詳情 | 供應商 | ||
| 112018-12-9 | 5,8-Epoxy-13-cis Retinoic Acid (Mixture of DIAStereomers) | 無 | 詳情 | 供應商 | ||
| 181208-36-6 | 6,7-Epoxy Docetaxel (Mixture of DIAStereomers) | 無 | 詳情 | 供應商 | ||